Equities analysts forecast that The Beauty Health Company (NASDAQ:SKIN) will report earnings of ($0.03) per share for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for Beauty Health’s earnings, with the lowest EPS estimate coming in at ($0.04) and the highest estimate coming in at ($0.02). The company is expected to issue its next earnings results after the market closes on Tuesday, February 22nd.

On average, analysts expect that Beauty Health will report full year earnings of ($3.29) per share for the current fiscal year, with EPS estimates ranging from ($3.62) to ($2.89). For the next year, analysts anticipate that the business will report earnings of $0.00 per share, with EPS estimates ranging from ($0.04) to $0.04. Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Beauty Health.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings results on Monday, November 8th. The company reported ($1.63) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.03) by ($1.60). The firm had revenue of $68.15 million during the quarter, compared to analyst estimates of $59.57 million.

A number of brokerages have commented on SKIN. Zacks Investment Research cut shares of Beauty Health from a “buy” rating to a “hold” rating in a research report on Saturday, January 29th. William Blair began coverage on Beauty Health in a report on Friday, January 7th. They issued an “outperform” rating on the stock. DA Davidson boosted their price target on Beauty Health from $26.00 to $32.00 and gave the stock a “buy” rating in a research report on Wednesday, November 10th. Finally, Raymond James initiated coverage on Beauty Health in a research note on Thursday, December 23rd. They issued a “market perform” rating for the company. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $28.22.

Beauty Health stock opened at $13.50 on Tuesday. Beauty Health has a 52 week low of $9.71 and a 52 week high of $30.17. The stock has a 50-day simple moving average of $19.53 and a 200 day simple moving average of $23.08.

Several institutional investors and hedge funds have recently modified their holdings of the company. PNC Financial Services Group Inc. grew its position in shares of Beauty Health by 47.5% during the 3rd quarter. PNC Financial Services Group Inc. now owns 1,962 shares of the company’s stock worth $50,000 after buying an additional 632 shares during the period. Emfo LLC purchased a new position in Beauty Health in the 3rd quarter worth approximately $78,000. Logan Capital Management Inc. purchased a new stake in shares of Beauty Health in the 3rd quarter valued at $78,000. Lindbrook Capital LLC purchased a new stake in Beauty Health during the 4th quarter valued at $74,000. Finally, First Mercantile Trust Co. bought a new position in Beauty Health in the 3rd quarter worth $82,000. 62.08% of the stock is currently owned by institutional investors.

Beauty Health Company Profile

Edge Systems, LLC designs, develops, manufactures, markets, and sells aesthetic technologies and products. It offers hydradermabrasion system that enhances the skin to cleanse, exfoliate, extract, and hydrate simultaneously; Hydraglucan Intense Hydration Booster, a customization for the HydraFacial treatment exfoliates the skin by improving cell renewal and delivers ingredients, including hyaluronic acid, glucan, and betaine to hydrate the skin and provide anti-aging benefits; HydraFacial Daily Essentials, which provides detoxification, rejuvenation, and protection of skin; crystal microdermabrasion systems; and light emitting diode systems.

See Also

Get a free copy of the Zacks research report on Beauty Health (SKIN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com